PERFLUOROPROPANE FOR PNEUMATIC RETINOPEXY

Gases Used Within Eye To Place Pressure On Detached Retina

FDA Premarket Approval P900066 S004

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for a change to the toxicity test protocol to increase the number of samples to be tested from each production lot of perfluoropropane from one sample per lot to three samples per lot.

DevicePERFLUOROPROPANE FOR PNEUMATIC RETINOPEXY
Classification NameGases Used Within Eye To Place Pressure On Detached Retina
Generic NameGases Used Within Eye To Place Pressure On Detached Retina
ApplicantAirgas USA, LLC
Date Received2000-08-18
Decision Date2000-09-05
PMAP900066
SupplementS004
Product CodeLPO
Advisory CommitteeOphthalmic
Supplement TypeSpecial (immediate Track)
Supplement ReasonPostapproval Study Protocol - Ode/oir
Expedited ReviewNo
Combination Product No
Applicant Address Airgas USA, LLC 6141 Easton Road plumsteadville, PA 18949

Supplemental Filings

Supplement NumberDateSupplement Type
P900066Original Filing
S015 2022-01-06 30-day Notice
S014
S013 2021-08-31 30-day Notice
S012
S011 2011-12-06 30-day Notice
S010 2010-07-19 30-day Notice
S009 2009-08-13 Special (immediate Track)
S008 2008-07-21 135 Review Track For 30-day Notice
S007
S006 2002-08-13 135 Review Track For 30-day Notice
S005 2001-12-26 Special (immediate Track)
S004 2000-08-18 Special (immediate Track)
S003 1999-09-21 Normal 180 Day Track
S002 1996-08-23 Normal 180 Day Track
S001

NIH GUDID Devices

Device IDPMASupp
00380657971039 P900066 000
00380657971022 P900066 000
00380657971015 P900066 000
00380657971053 P900066 002
00380657971046 P900066 002

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.